Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).

Literature DB >> 25815296

Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).

Seiichi Sakamoto¹, Hiroyuki Tanaka¹, Satoshi Morimoto¹.

Abstract

Entities: Disease Species

Year: 2015 PMID： 25815296 PMCID： PMC4356854 DOI： 10.3978/j.issn.2305-5839.2015.01.15

Source DB: PubMed Journal: Ann Transl Med ISSN： 2305-5839

× No keyword cloud information.

10 in total

Review 1. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

Authors: Daniel J Drucker; Michael A Nauck
Journal: Lancet Date: 2006-11-11 Impact factor: 79.321

2. Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.

Authors: M Gonzalez-Gronow; H E Grenett; M R Weber; G Gawdi; S V Pizzo
Journal: Biochem J Date: 2001-04-15 Impact factor: 3.857

3. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.

Authors: Liwei Jiang; Nianshuang Wang; Teng Zuo; Xuanling Shi; Kwok-Man Vincent Poon; Yongkang Wu; Fei Gao; Danyang Li; Ruoke Wang; Jianying Guo; Lili Fu; Kwok-Yung Yuen; Bo-Jian Zheng; Xinquan Wang; Linqi Zhang
Journal: Sci Transl Med Date: 2014-04-28 Impact factor: 17.956

4. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors: Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal: N Engl J Med Date: 2012-10-17 Impact factor: 91.245

5. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

Authors: C Morimoto; C I Lord; C Zhang; J S Duke-Cohan; N L Letvin; S F Schlossman
Journal: Proc Natl Acad Sci U S A Date: 1994-10-11 Impact factor: 11.205

6. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family.

Authors: N H Dang; Y Torimoto; S F Schlossman; C Morimoto
Journal: J Exp Med Date: 1990-08-01 Impact factor: 14.307

7. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4.

Authors: Nianshuang Wang; Xuanling Shi; Liwei Jiang; Senyan Zhang; Dongli Wang; Pei Tong; Dongxing Guo; Lili Fu; Ye Cui; Xi Liu; Kelly C Arledge; Ying-Hua Chen; Linqi Zhang; Xinquan Wang
Journal: Cell Res Date: 2013-07-09 Impact factor: 25.617

8. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques.

Authors: Darryl Falzarano; Emmie de Wit; Angela L Rasmussen; Friederike Feldmann; Atsushi Okumura; Dana P Scott; Doug Brining; Trenton Bushmaker; Cynthia Martellaro; Laura Baseler; Arndt G Benecke; Michael G Katze; Vincent J Munster; Heinz Feldmann
Journal: Nat Med Date: 2013-09-08 Impact factor: 53.440

Review 9. MERS: emergence of a novel human coronavirus.

Authors: V Stalin Raj; Albert D M E Osterhaus; Ron A M Fouchier; Bart L Haagmans
Journal: Curr Opin Virol Date: 2014-02-28 Impact factor: 7.090

10. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.

Authors: V Stalin Raj; Huihui Mou; Saskia L Smits; Dick H W Dekkers; Marcel A Müller; Ronald Dijkman; Doreen Muth; Jeroen A A Demmers; Ali Zaki; Ron A M Fouchier; Volker Thiel; Christian Drosten; Peter J M Rottier; Albert D M E Osterhaus; Berend Jan Bosch; Bart L Haagmans
Journal: Nature Date: 2013-03-14 Impact factor: 49.962

10 in total

7 in total

Review 7. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review.

Authors: Sabeena Mustafa; Hanan Balkhy; Musa N Gabere
Journal: J Infect Public Health Date: 2017-08-31 Impact factor: 3.718

7 in total

Towards the prophylactic and therapeutic use of human neutralizing monoclonal antibodies for Middle East respiratory syndrome coronavirus (MERS-CoV).

Review 1. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

2. Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells.

3. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.

4. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

5. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.

6. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family.

7. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4.

8. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques.

Review 9. MERS: emergence of a novel human coronavirus.

10. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.

1. A database of anti-coronavirus peptides.

2. Treatment strategies for Middle East respiratory syndrome coronavirus.

3. MERS may not be SARS; but India is still vulnerable.

4. Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis.

Review 5. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Review 6. A review of treatment modalities for Middle East Respiratory Syndrome.

Review 7. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review.